Minimum Requirements in Emergency Kits for Bailout Strategies in TAVR Complications

Overview

Journal J Card Surg

Specialties Cardiology & Vascular Diseases
General Surgery

Date 2022 Mar 6

PMID 35249238

Authors

Marco Gennari

Gilbert H L Tang

Maurizio Taramasso

Giulio Russo

Philipp K Haager

Marco Barbanti

Ana Paula Tagliari

Francesco Maisano

Affiliations

Soon will be listed here.

Abstract

Introduction: The proportion of patients with symptomatic severe aortic stenosis treated by transcatheter aortic valve replacement (TAVR) is increasing, driven by favorable outcomes from randomized trials and current valve guidelines recommendations. Despite device and technique improvements having reduced procedural morbidities, complications during or immediately after TAVR still carries significant mortality risk.

Methods: We propose a check-list of essential items to anticipate potentially life-threatening complications in TAVR.

Results: Purpose of this review is to discuss the most common life-threatening complications during TAVR from a troubleshooting perspective, depicting the minimum required equipment needed in emergency situations.

Conclusions: Prevention of complications remains the most important strategy to optimize outcomes in TAVR procedures. Each specialized Center should institute and make easily accessible standardized emergency kits for the most common life-threatening conditions during TAVR that should be readily available in the cath-lab or hybrid operating room.

Citing Articles

Minimum requirements in emergency kits for bailout strategies in TAVR complications.

Gennari M, Tang G, Taramasso M, Russo G, Haager P, Barbanti M J Card Surg. 2022; 37(7):2053-2059.

PMID: 35249238 PMC: 9311222. DOI: 10.1111/jocs.16380.

References

Hodson R, Jin R, Ring M, Gafoor S, Verburg S, Lehr E . Intrathoracic complications associated with trans-femoral transcatheter aortic valve replacement: Implications for emergency surgical preparedness. Catheter Cardiovasc Interv. 2019; 96(3):E369-E376. DOI: 10.1002/ccd.28620. View

Jabbour R, Tanaka A, Finkelstein A, Mack M, Tamburino C, van Mieghem N . Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2018; 71(14):1513-1524. DOI: 10.1016/j.jacc.2018.01.066. View

Elbadawi A, Saad M, Elgendy I, Barssoum K, Omer M, Soliman A . Temporal Trends and Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis. JACC Cardiovasc Interv. 2019; 12(18):1811-1822. DOI: 10.1016/j.jcin.2019.06.037. View

B Ribeiro H, Webb J, Makkar R, Cohen M, Kapadia S, Kodali S . Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol. 2013; 62(17):1552-62. DOI: 10.1016/j.jacc.2013.07.040. View

Zia S, Singh K, Juneja A, Schor J, Deitch J . Safety and Feasibility of Transradial Access for Noncoronary and Peripheral Vascular Interventions. Ann Vasc Surg. 2018; 53:255-261. DOI: 10.1016/j.avsg.2018.04.003. View

Bernardi F, Dvir D, Rodes-Cabau J, B Ribeiro H . Valve-in-Valve Challenges: How to Avoid Coronary Obstruction. Front Cardiovasc Med. 2019; 6:120. PMC: 6716332. DOI: 10.3389/fcvm.2019.00120. View

Walther T, Hamm C, Schuler G, Berkowitsch A, Kotting J, Mangner N . Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. J Am Coll Cardiol. 2015; 65(20):2173-80. DOI: 10.1016/j.jacc.2015.03.034. View

Auffret V, Lefevre T, Van Belle E, Eltchaninoff H, Iung B, Koning R . Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol. 2017; 70(1):42-55. DOI: 10.1016/j.jacc.2017.04.053. View

Maggiolini S, De Carlini C, Imazio M . Evolution of the pericardiocentesis technique. J Cardiovasc Med (Hagerstown). 2018; 19(6):267-273. DOI: 10.2459/JCM.0000000000000649. View

10.

Khan J, Dvir D, Greenbaum A, Babaliaros V, Rogers T, Aldea G . Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human. JACC Cardiovasc Interv. 2018; 11(7):677-689. PMC: 6309616. DOI: 10.1016/j.jcin.2018.01.247. View

11.

Siontis G, Juni P, Pilgrim T, Stortecky S, Bullesfeld L, Meier B . Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014; 64(2):129-40. DOI: 10.1016/j.jacc.2014.04.033. View

12.

Kim W, Schafer U, Tchetche D, Nef H, Arnold M, Avanzas P . Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration). Eur Heart J. 2019; 40(38):3156-3165. DOI: 10.1093/eurheartj/ehz429. View

13.

Genereux P, Piazza N, Alu M, Nazif T, Hahn R, Pibarot P . Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. J Am Coll Cardiol. 2021; 77(21):2717-2746. DOI: 10.1016/j.jacc.2021.02.038. View

14.

Banjac I, Petrovic M, Akay M, Janowiak L, Radovancevic R, Nathan S . Extracorporeal Membrane Oxygenation as a Procedural Rescue Strategy for Transcatheter Aortic Valve Replacement Cardiac Complications. ASAIO J. 2015; 62(1):e1-4. DOI: 10.1097/MAT.0000000000000275. View

15.

Pineda A, Harrison J, Kleiman N, Rihal C, Kodali S, Kirtane A . Incidence and Outcomes of Surgical Bailout During TAVR: Insights From the STS/ACC TVT Registry. JACC Cardiovasc Interv. 2019; 12(18):1751-1764. DOI: 10.1016/j.jcin.2019.04.026. View

16.

Khan J, Greenbaum A, Babaliaros V, Rogers T, Eng M, Paone G . The BASILICA Trial: Prospective Multicenter Investigation of Intentional Leaflet Laceration to Prevent TAVR Coronary Obstruction. JACC Cardiovasc Interv. 2019; 12(13):1240-1252. PMC: 6669893. DOI: 10.1016/j.jcin.2019.03.035. View

17.

Reardon M, Van Mieghem N, Popma J, Kleiman N, Sondergaard L, Mumtaz M . Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017; 376(14):1321-1331. DOI: 10.1056/NEJMoa1700456. View

18.

Vahanian A, Praz F, Milojevic M, Beyersdorf F . The "ten commandments" for the 2021 ESC/EACTS Guidelines on valvular heart disease. Eur Heart J. 2021; 42(41):4207-4208. DOI: 10.1093/eurheartj/ehab626. View

19.

Alkhouli M, Sievert H, Rihal C . Device Embolization in Structural Heart Interventions: Incidence, Outcomes, and Retrieval Techniques. JACC Cardiovasc Interv. 2019; 12(2):113-126. DOI: 10.1016/j.jcin.2018.08.033. View

20.

Eggebrecht H, Vaquerizo B, Moris C, Bossone E, Lammer J, Czerny M . Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI). Eur Heart J. 2017; 39(8):676-684. DOI: 10.1093/eurheartj/ehx713. View